Market Overview:
The global adjuvant therapy market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing demand for better treatment options, and technological advancements in the field of adjuvant therapy. Based on type, the global adjuvant therapy market is segmented into chemotherapy, radiotherapy, hormonotherapy, and others. Chemotherapy is further sub-segmented into alkylating agents, antimetabolites,, monoclonal antibodies (mAbs), plant alkaloids,, platinum analogs,, and topoisomerase inhibitors,. Radiotherapy is further sub-segmented into external beam radiation therapy (EBRT) and internal radiation therapy (IRT). Hormonotherapy is further sub-segmented into aromatase inhibitors,. Others include targeted therapies such as small molecule inhibitors/tyrosine kinase inhibitors (TKIs) and bisphosphonates. Based on application, the global adjuvant therapy market is segmented into hospital settings,, medical institutions,, other clinics or ambulatory care settings including cancer centers; private physician offices; home health care services; long term care facilities such as nursing homes; hospices;; military treatment facilities;; correctional facilities;; research laboratories/institutes ;and veterinary clinics. Geographically, the global adjuvant therapy market has been segmented into North America.
Product Definition:
Adjuvant therapy is the use of additional drugs, radiation, or surgery to increase the effectiveness of primary therapy. The importance of adjuvant therapy is that it can improve the cure rate for cancer patients.
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. Chemotherapy may be used in combination with radiation therapy, radiotherapy, surgery or a combination of these methods. The most common types of chemotherapy include alkylating agents such as busulfan, cytosine arabinoside (ara-C), and methylated DNA analogs such as 5-fluorouracil (Adrucil, 5-FU).
Radiotherapy:
Radiotherapy is a treatment using ionizing radiation. It's used in the treatment of various cancers and tumors, including breast cancer, cervical cancer, lung cancer, head & neck cancer and esophageal tumor. The most common side effects of radiotherapy include skin damage (such as burns), hair loss and nausea & vomiting.
Application Insights:
Based on application, the global adjuvant therapy market is segmented into hospital-based, medical institution-based and others. Others include research settings and private practices. The hospital-based segment held the largest share in 2017 owing to increasing usage of adjuvant therapies for treating various cancers at hospitals or cancer centers. This approach has shown significant success in reducing mortality rates among patients with different types of cancer as compared to chemotherapy alone.
Medical institutions are also expected to witness lucrative growth over the forecast period due to rising prevalence of several chronic diseases such as diabetes, which often goes hand in hand with cancer cells that need a longer treatment course than other noncancerous cells do.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of adjuvants developed by major companies and higher healthcare expenditure. In addition, increasing incidence rate of cancer is also one of the significant factors responsible for its largest share. For instance, as per statistics released by American Cancer Society in 2018, 1 out of 8 men and 1 out 5 women will be diagnosed with cancer during their lifetime in U.S., resulting into huge potential for growth over next eight years.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to rising incidences associated with cancers such as bladder & prostate gland (in men), breast (in women) and lung among others are anticipated to drive this regional market forward during the forecast period from 2018 to 2030 (see figure below).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the adjuvant therapy market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in 2017 in the U.S., and this number is expected to rise in the coming years. This will create a high demand for adjuvant therapies and drive the growth of this market.
- Growing awareness about adjuvant therapies: There is growing awareness among patients and healthcare professionals about adjuvant therapies and their benefits over other treatment options available for various cancers. This is driving demand for these therapies and propelling the growth of this market.
- Technological advancements in adjuvant therapy: The advent of novel technologies such as targeted therapy has revolutionized treatment options for various cancers, resulting in better patient outcomes with fewer side effects compared to traditional chemotherapy regimens or radiation therapy alone.. This is fueling demand for adjuvant therapies and driving their adoption across regions..
Scope Of The Report
Report Attributes
Report Details
Report Title
Adjuvant Therapy Market Research Report
By Type
Chemotherapy, Radiotherapy, Hormonotherapy, Others
By Application
Hospital, Medical Institution, Others
By Companies
Merck, Bayer, Johnson & Johnson, AstraZenca, Mylan, AbbVie, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Adjuvant Therapy Market Report Segments:
The global Adjuvant Therapy market is segmented on the basis of:
Types
Chemotherapy, Radiotherapy, Hormonotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Institution, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Bayer
- Johnson & Johnson
- AstraZenca
- Mylan
- AbbVie
- Novartis
Highlights of The Adjuvant Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Radiotherapy
- Hormonotherapy
- Others
- By Application:
- Hospital
- Medical Institution
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Adjuvant Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Adjuvant therapy is a type of treatment that is used in addition to standard treatments for cancer. Adjuvant therapy can help increase the effectiveness of standard treatments by helping to kill more cancer cells.
Some of the key players operating in the adjuvant therapy market are Merck, Bayer, Johnson & Johnson, AstraZenca, Mylan, AbbVie, Novartis.
The adjuvant therapy market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Adjuvant Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Adjuvant Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Adjuvant Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Adjuvant Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Adjuvant Therapy Market Size & Forecast, 2018-2028
4.5.1 Adjuvant Therapy Market Size and Y-o-Y Growth
4.5.2 Adjuvant Therapy Market Absolute $ Opportunity
Chapter 5 Global Adjuvant Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Adjuvant Therapy Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Radiotherapy
5.2.3 Hormonotherapy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Adjuvant Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Adjuvant Therapy Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Medical Institution
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Adjuvant Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Adjuvant Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Adjuvant Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Adjuvant Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Adjuvant Therapy Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Radiotherapy
9.6.3 Hormonotherapy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Adjuvant Therapy Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Medical Institution
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Adjuvant Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Adjuvant Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Adjuvant Therapy Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Radiotherapy
10.6.3 Hormonotherapy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Adjuvant Therapy Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Medical Institution
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Adjuvant Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Adjuvant Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Adjuvant Therapy Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Radiotherapy
11.6.3 Hormonotherapy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Adjuvant Therapy Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Medical Institution
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Adjuvant Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Adjuvant Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Adjuvant Therapy Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Radiotherapy
12.6.3 Hormonotherapy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Adjuvant Therapy Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Medical Institution
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Adjuvant Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Adjuvant Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Adjuvant Therapy Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Radiotherapy
13.6.3 Hormonotherapy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Adjuvant Therapy Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Medical Institution
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Adjuvant Therapy Market: Competitive Dashboard
14.2 Global Adjuvant Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Bayer
14.3.3 Johnson & Johnson
14.3.4 AstraZenca
14.3.5 Mylan
14.3.6 AbbVie
14.3.7 Novartis
